NACD, Ridge Global, and the Software Engineering Institute at Carnegie Mellon University Announce Cyber-Risk Oversight Program for Corporate Directors
WASHINGTON, 2016-09-14 15:00 CEST (GLOBE NEWSWIRE) --
With the critical issue of cyber-risk oversight at the top of every board’s agenda, the National Association of Corporate Directors (NACD), Ridge Global, and the CERT Division of the Software Engineering Institute at Carnegie Mellon Universitytoday announced the development of the first-ever NACD Cyber-Risk Oversight Program for corporate directors, which confers the CERT Certificate in Cybersecurity Oversight.
The program brings together the professional-development capabilities of NACD, the standard setter for responsible board leadership; Ridge Global’s experience supporting C-suite executives and board leaders; and the deep cyber-technical expertise of the world-renowned SEI CERT Division to deliver a cyber education and resource program that addresses the specific cyber-risk oversight responsibilities of board members and executives.
“While NACD’s latest governance survey found that only 14 percent of respondents believe their boards have a high level of understanding of the risks associated with cybersecurity,” said NACD’s CEO Ken Daly, “our director members across the country have demonstrated a strong interest in enhancing their cyber-risk oversight capabilities.”
The NACD Cyber-Risk Oversight Program will include the CERT Certificate in Cybersecurity Oversight, along with multiple NACD resources on cyber-risk oversight such as NACD’s Director’s Handbook on Cyber-Risk Oversight, the first private-sector resource to be featured on the Department of Homeland Security’s C3 Voluntary Program website.
“The SEI’s CERT Division has long advocated that authority for enterprise security should be held at the governance level of organizations—in boards of directors and senior executives,” said Robert F. Behler, deputy director and COO of the SEI. “The NACD Cyber-Risk Oversight Program will help senior leaders understand, achieve, and sustain an organization’s position on cyber risk.”
The program will be delivered completely online, allowing busy corporate directors and executives to complete the certificate from any location and at their own pace. The robust, multi-module certificate program will improve corporate directors’ understanding of cybersecurity risks, detail the respective responsibilities of the board and C-suite executives in cyber-risk oversight, and engage participants in a cyber-crisis simulation. The course will culminate in a comprehensive exam. Upon successful completion of the exam, participants will earn the CERT Certificate in Cybersecurity Oversight.
“Cyber threats have added another complex layer for corporate directors as they help to manage 21st century business risk,” said Gov. Tom Ridge, the first U.S. Secretary of Homeland Security and CEO of Ridge Global. “Ridge Global is pleased to partner with NACD and the SEI on this innovative program to help board members and executives strengthen their ability to work with both IT and enterprise leaders to more effectively evaluate and reduce digital risk.”
The NACD Cyber-Risk Oversight Program is expected to be available in late 2016.
Visit www.NACDonline.org/CyberCertificate to request additional information about the NACD Cyber-Risk Oversight Program for corporate directors.
The National Association of Corporate Directors (NACD) empowers more than 17,000 directors to lead with confidence in the boardroom. As the recognized authority on leading boardroom practices, NACD helps boards strengthen investor trust and public confidence by ensuring that today’s directors are well-prepared for tomorrow’s challenges. World-class boards join NACD to elevate performance, gain foresight, and instill confidence. Fostering collaboration among directors, investors, and governance stakeholders, NACD has been setting the standard for responsible board leadership for 40 years. To learn more about NACD, visit www.NACDonline.org. To become an NACD member, please contact Steve Kalan at Join@NACDonline.org or 202-572-2089. If you are already a member, contact your NACD Membership Advisor at MembershipAdvisor@NACDonline.org to ensure that you are receiving the best value from your membership.
About Ridge Global
Ridge Global is the risk management firm led by Tom Ridge, the first U.S. Secretary of Homeland Security and 43rd Governor of Pennsylvania. Ridge Global works with C-suite and board executives around the world to reduce enterprise cyber risk and to build more resilient organizations through innovative protection and response capabilities, cyber education and insurance solutions. Learn more at www.ridgeglobal.com.
About the Software Engineering Institute
The Software Engineering Institute (SEI) is a federally funded research and development center sponsored by the U.S. Department of Defense and operated by Carnegie Mellon University. The SEI works with organizations to make measurable improvements in their software engineering capabilities by providing technical leadership to advance the practice of software engineering. For more information, visit the SEI website at www.sei.cmu.edu. The CERT Division of the SEI is the world’s leading trusted authority dedicated to improving the security and resilience of computer systems and networks and a national asset in the field of cybersecurity. For more information, visit www.cert.org.
Software Engineering Institute
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
Payvision's annual report reveals cross-border ecommerce trends in 201719.10.2017 09:00 | Pressemelding
With online marketplaces and consumer technology leading the way for growth AMSTERDAM, The Netherlands, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Payvision, global acquirer and data-driven omnichannel solutions provider, has published the findings of its fifth annual cross-border ecommerce research report, in collaboration with Juniper Research. The paper includes the results of a global survey of various industry players regarding the game-changers, the biggest challenges, the best practices for going cross-border, and much more. When compared to last year's findings, the report reveals a new and exciting context for global cross-border trade. The compound annual growth rate predicted for the next three years for cross-border ecommerce is now 17%, whereas it stands at just 12% for ecommerce overall. Also, over the past 12 months, merchants' attitudes towards cross-border ecommerce have become more positive, with 50% of respondents agreeing and 31% strongly
High Seizure Frequency in Children with Dravet Syndrome Negatively Impacts Quality of Life, New International Caregiver Survey Finds19.10.2017 08:00 | Pressemelding
Global survey of 584 caregivers of children, young adults and adults with Dravet illustrates the detrimental effect of debilitating, frequent seizures on quality of life and co-morbidities Results suggest a need for more effective antiepileptic treatments EMERYVILLE, Calif. and BREST, France, Oct. 19, 2017 (GLOBE NEWSWIRE) -- The Dravet Syndrome European Federation and Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, announced today the publication of the initial results from a landmark survey into the clinical, social and economic consequences of Dravet syndrome on children, young adults and their families in Developmental Medicine & Child Neurology [doi:10.1111/dmcn.13591]. This study was led by Lieven Lagae, M.D., Ph.D., Professor at the University of Leuven, Belgium, Head of the Pediatric Neurology Department and Director of the Childhood Epilepsy
XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer18.10.2017 16:53 | Pressemelding
AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has begun treatment at Cedars-Sinai Medical Center under the care of Dr. Andrew Hendifar, the Study's Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai. A total of 16 patients are expected to be enrolled in the study. Dr. Hendifar commented, "We are excited to enroll our first patient in this novel combinatorial therapy for the treatment of advanced pancreatic cancer and cachexia. This is the first attempt to add an anti-inflammatory therapy to standard chemotherapy in an effort to improve the performanc
Nasdaq and SGX Establish Collaborative Listings Agreement18.10.2017 15:42 | Pressemelding
NEW YORK and SINGAPORE, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (Nasdaq:NDAQ) and Singapore Exchange (SGX) today announced the signing of a collaborative agreement in a move to leverage their strengths as two of the leading listings venues in the U.S. and Asia respectively. The new agreement seeks to enhance the channels available for companies to access capital market funding and enhance their corporate profile in both markets. As part of this agreement, Nasdaq and SGX -- who also share a successful, long-term market technology relationship -- are currently exploring the demand among corporates for a concurrent or sequential listing on both exchanges. Nasdaq and SGX are committed to supporting companies that are interested in pursuing this route. "The business landscape today is borderless," said Loh Boon Chye, CEO, SGX. "Fast-growing Asian companies looking to tap the capital markets can choose to list on SGX on Asian home ground, and embark on a listing on Nasdaq
Colliers International Expands in Washington, D.C.18.10.2017 14:30 | Pressemelding
Acquisition of Beltway Real Estate Services Firm Strengthens Ongoing Commitment to the Region TORONTO and WASHINGTON, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI)(TSX:CIGI) announced today the acquisition of leading tenant representation advisory firm Serten Advisors. With its office in Tysons Corner, the firm serves global, national, and regional clients with a highly skilled and experienced team of professionals that have more than 100 years of combined experience. "This strategic acquisition positions Colliers to gain additional market share and win new business in the vibrant and competitive Suburban DC markets," said Marty Pupil, Colliers International President | U.S. Brokerage. "Adding Steve and Paul and the rest of their talented leadership team to our existing group of professionals in the region will further position Colliers as the commercial real estate services firm of
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC18.10.2017 14:00 | Pressemelding
InSphero AG / InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the utility of its new 3D InSight(TM) Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs. The findings will be presented at oral and poster presentations this Friday at the annual meeting of the American Association for the Study of Liver Disease (AASLD) Conference in Washington, DC. Anti-fibrotic therapi
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom